Clinical Trials Browser

Phase 1/2 × Completed × Cachexia × Clear all

NCT00933361 2017-08-01

Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study

Phase 1/2 Completed

Cachexia